View More
Downloadable slideset from Clinical Care Options on key aspects of HCV pharmacy service provision, with insights from expert faculty
John Faragon, PharmD, BCPS, AAHIVP
Michelle T. Martin, PharmD, FCCP, BCPS, BCACP
Released: February 4, 2019
Expert commentary from Dr. Susanna Naggie on how to manage drug–drug interactions between ART and HCV regimens during HCV/HIV coinfection.
Susanna Naggie, MD, MHS
Released: January 25, 2019
Find out what pharmacists can do to expand and improve HCV service provision in this interactive CME/CPE module from Clinical Care Options
John Faragon, PharmD, BCPS, AAHIVP
Aileen Chi, PharmD
Physicians:
maximum of 0.75 AMA PRA Category 1 Credits™
Pharmacists:
0.75 contact hours (0.075 CEUs)
Released: January 11, 2019
Expiration: January 10, 2020
Downloadable slideset from Clinical Care Options on key aspects of HCV pharmacy service provision, with insights from Aileen Chi, PharmD
Aileen Chi, PharmD
Released: January 11, 2019
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.